Last reviewed · How we verify
NCT06171763
The Multi-stakeholder Assessment of Economic and Managerial Determinants and Impacts of Telemedicine
NA trial testing Telemedicine in Telemedicine in 150 participants. Completed in 8 November 2023.
30 September 2023
Quick facts
| Lead sponsor | Buzzi Children's Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 150 |
| Start date | 8 August 2022 |
| Primary completion | 30 September 2023 |
| Estimated completion | 8 November 2023 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Telemedicine
Conditions studied
- Telemedicine — all drugs for Telemedicine →
Sponsor
Buzzi Children's Hospital
Who can join
Adults 12 Months to 18, any sex, with Telemedicine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to conduct a comprehensive evaluation involving multiple stakeholders to assess the factors influencing and the consequences of telehomecare in comparison to traditional care models. The integration of technology into the healthcare sector necessitates significant changes in care of patients, organizational structures, production processes, organizational responsibilities, and the management of service delivery processes. The delivery of telemedicine services through integrated devices represents a method of service production that demands active involvement from patients or, in the case of pediatric patients, their caregivers. This collaborative process of patient engagement in healthcare services is referred to as "co-production." In this research, telehomecare will be examined as an illustrative instance of co-producing healthcare services. Co-production implies that the inputs into a production process are contributed not only by the organization producing a good or service but also by the users. In the case study, co-production occurs through the interaction between patients/caregivers and professionals during telehealth visits for device-mediated monitoring activities. Throughout the televisit, patients/caregivers play a crucial role in collecting and sharing the necessary parameters with professionals using the device, thereby serving as essential actors in the care process. The investigators explored the impact of a transitional care program, utilizing an user-friendly mobile medical device, to support an early discharges in a pediatric setting. Clinical outcome and economic advantages are considered. This study will contribute to implement knowledge on the role of telemedicine on HaH healthcare in pediatrics.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Leveraging User-Friendly Mobile Medical Devices to Facilitate Early Hospital Discharges in a Pediatric Setting: A Randomized Trial Study Protocol
Zuccotti G, Marsilio M, Fiori L, Erba P, et al · · 2024
Verify or expand the search:
- PubMed search for NCT06171763
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Telemedicine
Trials testing the same drug.
- NCT07059884 — Distance-Based Exercise to Preserve Function and Prevent Disability · NA · recruiting
- NCT07091617 — Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer · NA · recruiting
- NCT07027813 — Feasibility and Efficacy of Ambulance-Based m-Health for Pediatric Emergencies (FEAMER) Trial · NA · recruiting
- NCT07124546 — Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancer · NA · recruiting
- NCT06896539 — Telemedicine for Contraceptive Counselling- An Open Randomized Controlled Trial · NA · not yet recruiting
Other recruiting trials for Telemedicine
Currently open trials in the same condition.
- NCT07265037 — Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management · NA · recruiting
- NCT07042477 — Integrated Telemedicine Program Evaluation · NA · recruiting
- NCT07124325 — Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care · NA · recruiting
- NCT06942533 — Effect of Visual Feedback From the SpiroGym Mobile Application · NA · recruiting
- NCT06980740 — Video-Tumorboard PLUS · recruiting
Other Buzzi Children's Hospital trials
Trials by the same sponsor.
- NCT07250074 — "Sentinella": Registry and Training for Child Protection · not yet recruiting
- NCT06427564 — Vital Signs Collection Via "Comestai" App · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06171763 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Buzzi Children's Hospital
- Last refreshed: 20 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06171763.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing